Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA Comparison in Adolescent Idiopathic Scoliosis Surgery
NCT06096181Phase 2Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in adolescent idiopathic scoliosis (AIS), sponsored by Cedars-Sinai Medical Center. Started Dec 2023; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT06096181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06096181.